Current Treatment of Pulmonary Embolism
Abstract
Pulmonary embolism remains a major contributor to global disease burden. Risk-adapted treatment and follow-up contributes to a favorable outcome. The recommended definitive treatment for patients with high risk pulmonary embolism is thrombolysis. For patients with a contraindication to anticoagulation and thrombolytic therapy, surgical embolectomy and catheter-based therapies are options. In patients with intermediate-high risk pulmonary embolism, initiation of parenteral anticoagulation is recommended withour delay and thrombolytic therapy should only be given in case of hemodynamic worsening. Finally, direct oral anticoagulants have been shown to be as effective as and safer than the combination of low molecular weight heparin and vitamin K antagonist(s) in patients with low- to intermediate-risk pulmonary embolism.
Keywords
References
- White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107:14-18.
- Demir M, Erdemli B, Kurtoğlu M, Öngen G. Ulusal Venöz Tromboembolizm Profilaksi ve Tedavi Kılavuzu. İstanbul, Cortex, 2010.
- Ghignone M, Girling L, Prewitt RM. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology. 1984;60:132-5.
- Mercat A, Diehl JL, Meyer G, Teboul JL, Sors H. Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med. 1999;27:540-4.
- Prewitt RM. Hemodynamic management in pulmonary embolism and acute hypoxemic respiratory failure. Crit Care Med. 1990;18:61-9.
- Manier G, Castaing Y. Influence of cardiac output on oxygen exchange in acute pulmonary embolism. Am Rev Respir Dis. 1992;145:130-6.
- Capellier G, Jacques T, Balvay P, Blasco G, Belle E, Barale F. Inhaled nitric oxide in patients with pulmonary embolism. Intensive Care Med. 1997;23:1089-92.
- Szold O, KhouryW, Biderman P, Klausner JM, Halpern P,Weinbroum AA. Inhaled nitric oxide improves pulmonary functions following massive pulmonary embolism: a report of four patients and review of the literature. Lung. 2006;184:1-5.
- Kerbaul F, Gariboldi V, Giorgi R, Mekkaoui C, Guieu R, Fesler P et al. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure. Crit Care Med. 2007;35:1948-54.
- Konstantinides S, Geibel A, Kasper W, Olschewski M, Blumel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation. 1998;97:1946-51.
